Quality of life, neurocognitive functioning, psychological issues, sexuality and comorbidity more than 2 years after commencing immune checkpoint inhibitor treatment

Background Increasing numbers of patients diagnosed with advanced cancer survive long-term after treatment with immune checkpoint inhibitors (ICIs). To design adequate interventions for these survivors, knowledge regarding quality of life (QOL) and its association with long-term and late effects of...

詳細記述

書誌詳細

主要な著者:	Melanie M van der Klauw, T Jeroen N Hiltermann, Mathilde Jalving, Emoke Racz, Sjoukje Oosting, Anna K L Reyners, Wellington Candido, Annemarie Cecile Eggen, Ingeborg Bosma, Reinate D Horinga, Kelly C van Heuvelen, Janine Nuver
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMJ Publishing Group 2025-03-01
シリーズ:	Journal for ImmunoTherapy of Cancer
オンライン･アクセス:	https://jitc.bmj.com/content/13/3/e011168.full
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!